Oxford Performance Materials, Inc. (OPM), a leader in advanced materials science and high performance additive manufacturing (HPAM), today announced that it has closed on an additional round of strategic investment from Hexcel Corporation. In May 2016, OPM and Hexcel announced an initial strategic investment from Hexcel of $15 million. The second round of investment from Hexcel is $10 million, for a total equity investment of $25 million to date.
OPM develops proprietary material, process and application technologies, and its Aerospace & Industrial business unit applies 3D printing technology and HPAM™ to produce fully functional end-use parts that combine structural strength, enhanced performance, weight reduction and time-to-market benefits for its customer base.
Hexcel is a global leader in advanced composites technology with headquarters in Connecticut and manufacturing locations worldwide. OPM Aerospace & Industrial utilizes Hexcel carbon fiber in the production of OPM’S 3D printed OXFAB®–ESD advanced thermoplastic structural parts for its aerospace, satellite & defense programs.
OPM recently announced its contract award from Boeing to supply 3D-printed OXFAB® structural production parts for the CST-100 Starliner. Hexcel’s follow-on investment will further enable OPM to expand capacity to meet rapidly growing market demand for the company’s OXFAB® technology in aerospace and other industries.
Oxford Performance Materials Inc. (OPM) was founded in 2000 to exploit and commercialize the world’s highest performing thermoplastics, with a focus on poly-ether-ketone-ketone (PEKK). OPM develops proprietary material, process and application technologies and applies high performance additive manufacturing (HPAM™) to produce fully functional end-use structural parts.
The Company has three strategic business units: OPM Materials develops proprietary OXPEKK® thermoplastic products and other materials for biomedical, aerospace and industrial applications. OPM Aerospace & Industrial produces 3D printed OXFAB® production parts for highly demanding aerospace, satellite and defense applications. OXFAB® structures offer significant weight, cost and time-to-market reductions that are defined in a set of specified performance attributes in the exhaustive OPM B-Basis database, developed in conjunction with NASA.
OPM Biomedical is a pioneer in personalized medicine, 3D printing OsteoFab® cranial and facial implants as an OEM, and its SpineFab® line on a contract manufacturing basis. OPM Biomedical is the first and only company to receive FDA 510(k) clearance to manufacture 3D printed patient-specific polymeric implants, and has a total of four 510(k) clearances in its portfolio.